This is a synthetic peptide designed for use in combination with anti-MAPT Antibody(ARP48104_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
MAPT
(Microtubule-Associated Protein tau (MAPT))
Hintergrund
MAPT is differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. The mutations in the gene have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
Alias Symbols: DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, TAU
Protein Interaction Partner: YWHAZ,GSK3B,AATF,ABL1,ACTB,APOE,ARHGEF40,CALM1,CAMK2A,CASP1,CASP3,CASP6,CASP7,CASP8,CDK1,CDK5,CDK5,CDK5,FYN,GSK3A,GSK3B,HSPA8,MAPK12,MAPT,MARK1,MARK4,OGT,PHKG1,PIN1,PKN1,PPP2CA,PPP2CB,PPP2R5A,PPP5C,PRKCD,PSEN1,RPS6KA3,RPS6KB1,S100B,SNCA,SPTB,STAU1,STUB1,S